Table 1.
Source, Year | Size of Study, Exposures, No. | Incident HCV, No. (%) | Comments |
---|---|---|---|
Hernandez et al, 1992 [7] | 81 | 0 (0) | Retrospective, needlestick injury, anti-HCV confirmation of source |
Mitsui et al, 1992 [8] | 68 | 7 (10) | Retrospective, needlestick injury, only analyzed source exposures with detectable HCV RNA |
Sodeyama et al, 1993 [9] | 92 | 3 (3.3) | Retrospective, needlestick injury, only analyzed source exposures with detectable HCV RNA |
Lanphear et al, 1994 [10] | 50 | 3 (6) | Retrospective, needlestick injury, anti-HCV confirmation of source |
Puro et al, 1995 [11] | 331 | 4 (1.2) | Prospective, needlestick injury, anti-HCV confirmation of source |
Aria et al, 1996 [12] | 56 | 3 (5.4) | Prospective, needlestick injury |
Takagi et al, 1998 [13] | 251 | 4 (1.6) | Retrospective, multiple injury types (87.7% needlestick or suture/surgical) |
Hasan et al, 1999 [14] | 25 | 0 (0) | Prospective, needlestick injury, all source patients with detectable HCV RNA |
Baldo et al, 2002 [15] | 68 | 0 (0) | Prospective, all injuries included, only analyzed source exposures with detectable HCV RNA |
Chung et al, 2003 [16] | 405 | 1 (0.2) | Retrospective, needlestick injury, anti-HCV confirmation of source |
De Carli et al, 2003 [17] | 1876 | 14 (0.74) | Prospective, needlestick, anti-HCV confirmation of source |
Tomkins et al, 2012 [18] | 626 | 14 (2.2) | Retrospective, all injuries included, anti-HCV confirmation of source |
Abbreviations: HCV, hepatitis C virus; RNA, ribonucleic acid.